TY - JOUR
T1 - Can COVID-19 related mental health issues be measured?
AU - Ransing, Ramdas
AU - Ramalho, Rodrigo
AU - Orsolini, Laura
AU - Adiukwu, Frances
AU - Gonzalez-Diaz, Jairo M.
AU - Larnaout, Amine
AU - Pinto da Costa, Mariana
AU - Grandinetti, Paolo
AU - Bytyçi, Drita Gashi
AU - Shalbafan, Mohammadreza
AU - Patil, Ishwar
AU - Nofal, Marwa
AU - Pereira-Sanchez, Victor
AU - Kilic, Ozge
PY - 2020/5/26
Y1 - 2020/5/26
N2 - The COVID-19 pandemic and mitigation efforts carry a mental health toll among health care workers, individuals infected and the general population (Li et al., 2020, Ransing et al., 2020). There is a lack of specific robust screening tools or diagnostic instruments that could promptly identify relevant symptoms and contribute to the attempts to study the epidemiology of COVID-19 related mental health problems. In fact, the use of traditional assessment tools (e.g. PHQ-9, GAD-7) may lead to under-diagnosis or over-diagnosis of the cases emerging in this current pandemic due to their poor psychometric properties (e.g. face validity). There are new scales tailored to identify COVID-19 related mental health issues (Lee, 2020a, Taylor et al., 2020), however, their clinical utility, methodological strengths and limitations have not yet been explored in the literature. In this article we provide a brief overview of these new assessment tools, with a focus on their multi-language availability.Our search (till May 15, 2020) in PubMed, Scopus, and Google Scholar databases yielded five published new scales (Table 1 ) (Ahorsu et al., 2020, Lee, 2020a, Lee, 2020b, Taylor et al., 2020): Coronavirus Anxiety Scale (CAS) (Lee, 2020b), the Obsession with COVID-19 Scale (OCS) (Lee, 2020a), the Fear of COVID-19 Scale (FCV-19S) (Ahorsu et al., 2020), the COVID Stress Scales (CSS) (Taylor et al., 2020), and the Questionnaire on Perception of Threat from COVID-19 (Pérez-Fuentes et al., 2020). Almost all of them were developed as self-report and Likert-type scales and validated using online surveys. To our surprise, there was no available clinician-administered scale to measure psychological distress or disorders in the context of COVID-19 infection.
AB - The COVID-19 pandemic and mitigation efforts carry a mental health toll among health care workers, individuals infected and the general population (Li et al., 2020, Ransing et al., 2020). There is a lack of specific robust screening tools or diagnostic instruments that could promptly identify relevant symptoms and contribute to the attempts to study the epidemiology of COVID-19 related mental health problems. In fact, the use of traditional assessment tools (e.g. PHQ-9, GAD-7) may lead to under-diagnosis or over-diagnosis of the cases emerging in this current pandemic due to their poor psychometric properties (e.g. face validity). There are new scales tailored to identify COVID-19 related mental health issues (Lee, 2020a, Taylor et al., 2020), however, their clinical utility, methodological strengths and limitations have not yet been explored in the literature. In this article we provide a brief overview of these new assessment tools, with a focus on their multi-language availability.Our search (till May 15, 2020) in PubMed, Scopus, and Google Scholar databases yielded five published new scales (Table 1 ) (Ahorsu et al., 2020, Lee, 2020a, Lee, 2020b, Taylor et al., 2020): Coronavirus Anxiety Scale (CAS) (Lee, 2020b), the Obsession with COVID-19 Scale (OCS) (Lee, 2020a), the Fear of COVID-19 Scale (FCV-19S) (Ahorsu et al., 2020), the COVID Stress Scales (CSS) (Taylor et al., 2020), and the Questionnaire on Perception of Threat from COVID-19 (Pérez-Fuentes et al., 2020). Almost all of them were developed as self-report and Likert-type scales and validated using online surveys. To our surprise, there was no available clinician-administered scale to measure psychological distress or disorders in the context of COVID-19 infection.
UR - http://www.scopus.com/inward/record.url?scp=85086860486&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85086860486&partnerID=8YFLogxK
U2 - 10.1016/j.bbi.2020.05.049
DO - 10.1016/j.bbi.2020.05.049
M3 - Letter
C2 - 32470593
AN - SCOPUS:85086860486
SN - 0889-1591
VL - 88
SP - 32
EP - 34
JO - Brain, Behavior, and Immunity
JF - Brain, Behavior, and Immunity
ER -
